Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
Get the summary SWOT & PESTLE.com report delivered straight to your email inbox for free. Our insightful and holistic reports have helped corporates, academia and researchers take their research forward. You also agree to receive email updates from us on our new reports and solutions.

Fresenius SE & Co. SWOT & PESTLE Analysis

ID : 52794253| Oct 2020| 12 pages

COMPANY PROFILE -Fresenius SE & Co.

Business Sector :Pharma & Healthcare

Operating Geography :Germany, Europe, Global

About Fresenius SE & Co. :

Fresenius SE & Co. KGaA is a health care company primarily providing products and services for dialysis, hospitals along with inpatient and outpatient medical care. It was founded in 1912 by Eduard Fresenius. It is headquartered in Germany. The company is one of the world’s leading healthcare companies serving more than 100 countries around the globe. The Fresenius Group includes 4 independent business segments with each segment being active in a major area of growth in healthcare. The 4 groups are Fresenius Medical care which is the world leader in kidney failure treatment, Fresenius Helios which is Europe’s largest private hospital operator, Fresenius Kabi which supplies essential drugs and medical services to help critically ill patients and Fresenius Vamed which plans and manages healthcare facilities. The Group employed over 294,000 employees at the start of 2020.
Fresenius always keeps the patients first which has remained their unique selling proposition. They have been working for more than 100 years to save lives and improve the quality of life of their patients. With strong focus on innovation and efficiency, they have made quality healthcare services accessible to large number of people and work towards finding better solutions thus contributing to medical progress and better patient care. Their commitment to future is captured by “Forward Thinking Healthcare”: better medicine for more people.
Fresenius mission statement reads as “Better medicine and health care services for even more people”.

Fresenius SE & Co. Revenue :


€ 35.5 billion – FY ended 31st Dec 2019
€ 33.5 billion - FY ended 31st Dec 2018

Competitive Analysis of Fresenius SE & Co.

SWOT
PESTLE
The SWOT analysis for Fresenius SE & Co. is presented below in a table followed by the detailed analysis report.
StrengthsWeaknesses
1. Strong focus on research and development
2. World’s leading products and service provider for kidney patients
3. Consecutive record year with strong financial performance
4. Significant progress across four business groups
1. Voluntary recall of lots due to presence of particulate matter
OpportunitiesThreats
1. Increasing global dialysis market
2. Increasing opportunities in health care sector
3. Expanding the regional presence
4. Broadening the products and services business
1. Impact of regulatory changes on Fresenius Helios
2. Changes in health care and reimbursement systems related regulations
3. Re-entry of competitors into the U.S. market for generic IV drugs
SWOT & PESTLE (combined)
Complete Report
USD 27
*
  • with PayPal
  • with Debit/Credit card
Great quality, Affordable pricing.
Safe and secure payments
This is a custom report and will be delivered to your email inbox within 2 business days from purchase.

Detailed SWOT Analysis of Fresenius SE & Co.

Strength

1. Strong focus on research and development: Being one of the leading services providers in the healthcare segment, Fresenius attaches great importance to research and development. The Group stays updated with all latest technology and developments so as to serve the patients better and hence is incessantly involved in research. Fresenius Kabi in 2019 opened a research and development center in Switzerland for biosimilars. A biosimilar is a drug which is similar to another approved biologic drug. The German medical care company invested around €15 million which will further help in strengthening the company’s capability to develop new biosimilars specially in the areas of autoimmune and diseases and oncology. Fresenius Kabi formed a joint venture along with Bio-Techne and Wilson Wolf to support researchers and biopharmaceutical companies in cell and gene therapy fields. Fresenius Medical Care also expanded its clinical research activities by expanding the offerings of Frenova Renal Research, a subsidiary, which was previously limited to North America, to Europe, Middle east and Africa and Latin America.

The remaining section of “Strength” is available only in the 'Complete Report' on purchase.

Weakness

This section is available only in the 'Complete Report' on purchase.

Opportunity

1. Increasing global dialysis market:The global dialysis market has been increasing at a high rate with each passing year. In 2019, this market was approximated to be worth €80 billion and saw a growth of around 4%. Approximately 4.3 million people were treated worldwide with chronic renal failure out of which 3.5 million received dialysis treatments and about 815,000 were living with transplanted kidney. The major growth factor for the increasing dialysis market is the increasing number of patients with diabetes and blood pressure since these 2 diseases often precede the onset of chronic kidney failure. The number of dialysis patients increased by 6% worldwide. Around 10% of the worldwide dialysis patients are being treated by Fresenius Medical care. Fresenius Medical care is the leading provider of dialysis products in the world with a market share of 36%. With the momentous growth of the global dialysis market, Fresenius is well positioned to see healthy growth. https://www.fresenius.com/financial_reporting/Fresenius_Annual_Report_2019.pdf Page 47, 72

The remaining section of “Opportunity” is available only in the 'Complete Report' on purchase.

h2>Threats

This section is available only in the 'Complete Report' on purchase.

Major Competitors :

Major Brands :

  • Fresenius Medical Care
  • Fresenius Helios
  • Fresenius Kabi
  • Fresenius Vamed
SWOT & PESTLE (combined)
Complete Report
USD 27
*
  • with PayPal
  • with Debit/Credit card
Great quality, Affordable pricing.
Safe and secure payments
This is a custom report and will be delivered to your email inbox within 2 business days from purchase.

Check Out Analysis of Other Relevant Companies

TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
References used in Fresenius SE & Co. Analysis Report

1. Fresenius Medical Care expands collaboration with U.S. insurer Humana - https://www.fresenius.com/
2. Trump Administration Announces Plans To Shake Up The Kidney Care Industry - https://www.npr.org/sections/health-shots/2019/07/10/740276389/trump- administration-announces-plans-to-shake-up-the-kidney-care-industry
3. Fresenius Kabi's Recall of Ketorolac Results In QuVa Pharma® Recall of Compounded Sterile Product (R.E.C.K.) - https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ fresenius-kabis-recall-ketorolac-results-quva-pharmar-recall-compounded-sterile-product-reck
4. Annual Report 2019 - https://www.fresenius.com/financial_reporting/Fresenius_Annual_Report_2019.pdf
The detailed complete set of references are available on request in the 'Complete report' on purchase.

How to Reference This Page?

You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.

Fresenius SE & Co. SWOT & PESTLE Analysis - SWOT & PESTLE.COM

SWOT & PESTLE.com (2020). Fresenius SE & Co. SWOT & PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/fresenius-se-co/ [Accessed 28 Oct, 2020].

In-text: (SWOT & PESTLE.com, 2020)

Copyrights and Disclaimer

Fresenius SE & Co. SWOT & PESTLE analysis has been conducted by Sushree Lasyamayee and reviewed by senior analysts from Barakaat Consulting.

Copyright of Fresenius SE & Co. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.

You might also like to check out :
Fresenius SE & Co. SWOT & PESTLE Analysis
Price : USD 27